The Dutch government yesterday proposed legislation that would give it power to block or undo mergers in the telecommunications sector.
The Netherlands is gearing up for a national election on March 15 in which the ruling conservative VVD party is facing a strong challenge from the far-right nationalist Party for Freedom of Geert Wilders.
In a statement, the Dutch Ministry of Economic Affairs said telecommunications, including data hosting centers and other Internet infrastructure, was vital to national security and the law was permissible under EU rules.
“The Netherlands profits from the fact that we have an open economy,” Dutch Minister of Economic Affairs Henk Kamp said in a statement. “We take over more companies abroad than vice versa.”
However, the minister said “our country is not helped by takeovers by foreign companies that are linked to criminal activities, that are financially weak or that have a non-transparent ownership structure.”
He said the new law was needed to give a legal basis to prevent such takeovers.
Separately, Kamp said the government was seeking further powers over the national mail company, including insuring it remains headquartered in the Netherlands and makes sufficient infrastructure investments.
Last month, PostNL NV rejected a takeover offer from Belgian rival Bpost SA under pressure from the Dutch government.
Attempts by America Movil SAB, owned by Mexican tycoon Carlos Slim, to take over Dutch telecom KPN NV in 2013 foundered as the company took poison pill measures to prevent it.
In 2015, Britain’s NCC Group bought Dutch cybersecurity firm Fox-IT, which is responsible for securing Dutch government communications, for 133 million euros (US$141.5 million).
Now that Britain has voted to leave the EU, a Dutch newspaper reported the government has sought to have parts of Fox-IT’s business ring-fenced in a division called Fox Crypto that the Dutch government would exert considerable control over.
Those controls would include a veto right on board appointments and right of first refusal to purchase it if it was put up for sale.
UPGRADE AND TRANSFORM: Although the cross-strait trade deal might remain, the Ministry of Economic Affairs said businesses should prepare for any disruptions Taiwan might face a decline in foreign trade with China if the cross-strait Economic Cooperation Framework Agreement (ECFA) ends this year, Minister of Economic Affairs Shen Jong-chin (沈榮津) said yesterday. The agreement, which was signed and put into effect in 2010 to reduce trade barriers across the Taiwan Strait, is expected to end this year, despite not having an exact termination date. “We have not received notification [from China] that it wishes to terminate ECFA,” Shen told reporters prior to attending a meeting at the Legislative Yuan. “Even if we are notified, the agreement would only cease after six months.” While acknowledging the
The Ministry of Economic Affairs yesterday gave the green light to Good Way Technology Co’s (東碩資訊) application to invest up to NT$700 million (US$23.1 million) in Taiwan under a three-year program that provides incentives for overseas Taiwanese companies to invest back home. Good Way, which specializes in docking stations and counts Intel Corp among its major clients, plans to set up a manufacturing facility in New Taipei City’s Sijhih District (汐止), the ministry said in a statement. Good Way, which has a research and development facility in Taiwan and only one manufacturing plant — in Kunshan, China — decided to expand its
Novartis AG chief executive Vas Narasimhan said his Sandoz generics unit’s malaria, lupus and arthritis drug hydroxychloroquine is the company’s biggest hope against COVID-19, Swiss weekly SonntagsZeitung reported yesterday. Novartis has pledged to donate 130 million doses and is supporting clinical trials needed before the medicine, which US President Donald Trump also has been promoting, can be approved for use. Other companies including Bayer AG and Teva Pharmaceutical Industries Ltd have also agreed to donate hydroxychloroquine or similar drugs, while Gilead Sciences Inc is testing its experimental drug remdesivir against COVID-19. “Pre-clinical studies in animals, as well as the first data from clinical
Business sentiment in all industries last month weakened further as the number of COVID-19 infections escalated, threatening to push the global economy into a recession, the Taiwan Institute of Economic Research (TIER, 台經院) said yesterday. The business confidence gauge for local manufacturers fell 5.31 points to 88.73 from a month earlier, the lowest since January last year, a monthly survey by the Taipei-based institute indicated. Only 19.3 percent of manufacturers remained upbeat about their business outlook in the coming six months, 6 percentage points lower from a month earlier, while companies with a gloomy outlook rose 9.8 percentage points to 36.9 percent,